DealBook: SXC Health Solutions to Buy Catalyst for $4.4 Billion
SXC Health Solutions agreed on Wednesday to buy Catalyst for about $4.4 billion in cash and stock, uniting two companies in the drug benefits management sector.
Alle rechten voorbehouden © 2016 Van Zijtveld B.V. De installatie specialisten